These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18506854)
1. Proteasome activation as a novel antiaging strategy. Chondrogianni N; Gonos ES IUBMB Life; 2008 Oct; 60(10):651-5. PubMed ID: 18506854 [TBL] [Abstract][Full Text] [Related]
2. Proteasome dysfunction in mammalian aging: steps and factors involved. Chondrogianni N; Gonos ES Exp Gerontol; 2005 Dec; 40(12):931-8. PubMed ID: 16246514 [TBL] [Abstract][Full Text] [Related]
3. Proteasome function determines cellular homeostasis and the rate of aging. Chondrogianni N; Gonos ES Adv Exp Med Biol; 2010; 694():38-46. PubMed ID: 20886755 [TBL] [Abstract][Full Text] [Related]
4. [Proteasome and proteolysis]. Papapostolou D; Reboud-Ravaux M J Soc Biol; 2004; 198(3):263-78. PubMed ID: 15662944 [TBL] [Abstract][Full Text] [Related]
5. The role of ubiquitin-proteasome system in ageing. Löw P Gen Comp Endocrinol; 2011 May; 172(1):39-43. PubMed ID: 21324320 [TBL] [Abstract][Full Text] [Related]
6. The proteasome and its role in nuclear protein maintenance. Bader N; Jung T; Grune T Exp Gerontol; 2007 Sep; 42(9):864-70. PubMed ID: 17532163 [TBL] [Abstract][Full Text] [Related]
8. Changes of the proteasomal system during the aging process. Baraibar MA; Friguet B Prog Mol Biol Transl Sci; 2012; 109():249-75. PubMed ID: 22727424 [TBL] [Abstract][Full Text] [Related]
9. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Breusing N; Grune T Biol Chem; 2008 Mar; 389(3):203-9. PubMed ID: 18208355 [TBL] [Abstract][Full Text] [Related]
10. Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. Caballero M; Liton PB; Challa P; Epstein DL; Gonzalez P Biochem Biophys Res Commun; 2004 Oct; 323(3):1048-54. PubMed ID: 15381105 [TBL] [Abstract][Full Text] [Related]
11. Oxidative protein damage and the proteasome. Grimm S; Höhn A; Grune T Amino Acids; 2012 Jan; 42(1):23-38. PubMed ID: 20556625 [TBL] [Abstract][Full Text] [Related]
12. Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status. Chondrogianni N; Trougakos IP; Kletsas D; Chen QM; Gonos ES Aging Cell; 2008 Oct; 7(5):717-32. PubMed ID: 18691182 [TBL] [Abstract][Full Text] [Related]
13. Protein oxidation and proteolysis. Bader N; Grune T Biol Chem; 2006; 387(10-11):1351-5. PubMed ID: 17081106 [TBL] [Abstract][Full Text] [Related]
14. Phage-displayed antibodies for the detection of glycated proteasome in aging cells. Gonzalez-Dosal R; Sørensen MD; Clark BF; Rattan SI; Kristensen P Ann N Y Acad Sci; 2006 May; 1067():474-8. PubMed ID: 16804029 [TBL] [Abstract][Full Text] [Related]
15. The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts. Katsiki M; Chondrogianni N; Chinou I; Rivett AJ; Gonos ES Rejuvenation Res; 2007 Jun; 10(2):157-72. PubMed ID: 17518699 [TBL] [Abstract][Full Text] [Related]
16. Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors. Bayot A; Basse N; Lee I; Gareil M; Pirotte B; Bulteau AL; Friguet B; Reboud-Ravaux M Biochimie; 2008 Feb; 90(2):260-9. PubMed ID: 18021745 [TBL] [Abstract][Full Text] [Related]
18. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors. Sprangers R; Li X; Mao X; Rubinstein JL; Schimmer AD; Kay LE Biochemistry; 2008 Jul; 47(26):6727-34. PubMed ID: 18540636 [TBL] [Abstract][Full Text] [Related]
19. A protein silencing switch by ligand-induced proteasome-targeting intrabodies. Melchionna T; Cattaneo A J Mol Biol; 2007 Nov; 374(3):641-54. PubMed ID: 17950312 [TBL] [Abstract][Full Text] [Related]
20. Protein degradation and aging. Martinez-Vicente M; Sovak G; Cuervo AM Exp Gerontol; 2005; 40(8-9):622-33. PubMed ID: 16125351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]